5-HTT overexpression leads to the development of pulmonary hypertension (PH) and PA-SMC hyperplasia, and 5-HTT polymorphisms have been associated with disease development [1], [6], [7], [8]. This evidence concerns the gene SLC6A4 and pulmonary arterial hypertension.